10 results
Pulmonary Embolism - Risk Stratification and Prognostication based on scores and clinical features

 • Bova score
Pulmonary Embolism ... - Risk Stratification ... Prognostication based on scores ... features • Bova score ... #Embolism #Risk
The Wells, Geneva, and revised-Geneva pre-test possibility scores to risk-stratify patients with concern for PE

#Wells #Revised
to risk-stratify ... patients with concern ... Revised #Geneva #Risk ... #Stratification ... #Pulmonary #Embolism
CURB-65 Scoring and Treatment Options #Management #Pneumonia #Risk #Stratification #Admission #CURB65 #Criteria #Severity #Score
65 Scoring and Treatment ... Management #Pneumonia #Risk ... #Stratification ... Admission #CURB65 #Criteria ... #Severity #Score
Pulmonary Embolism Rule-Out Criteria

In the United States, the workup rate for PE is astonishingly high, with
Pulmonary Embolism ... recommend the use of risk ... stratification ... patients who are low risk ... PE, despite the risk
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... algorithm for the treatment ... of cancer-associated ... thrombosis; PE = pulmonary ... embolism; GI =
Pulmonary Embolism Severeity Index - estimates 30d mortality #Diagnosis #Management #EM #IM #PCC #PESI #sPESI #risk
Pulmonary Embolism ... Diagnosis #Management #EM ... #PESI #sPESI #risk ... #score #PE #PulmonaryEmbolism
#BOVA #score #pulmonary #embolism #Risk #factors

Basis underlying Bova score for PE complications/mortality. Factors associated with 30-day
#BOVA #score #pulmonary ... #embolism #Risk ... to identify low-risk ... comorbidities such as cancer ... of intermediate-risk
HESTIA Criteria for Outpatient Pulmonary Embolism Treatment - Identifies low-risk PE patients safe for outpatient treatment
HESTIA Criteria ... for Outpatient Pulmonary ... Embolism Treatment ... Identifies low-risk ... for outpatient treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
lymph nodes Risk ... Lymphoma • Lung cancer ... • Septic emboli ... Tuberculosis Treatment ... Inhibitor: • Risk
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
lymph nodes Risk ... Lymphoma • Lung cancer ... • Septic emboli ... Tuberculosis Treatment ... Inhibitor: • Risk